摘要 |
Examining a human sample for markers of liver diseases comprises detecting elevated levels of one or more proteins selected from ER60, vimentin, actin alpha 1 skeletal muscle protein, hMFAP 4, tropomyosin, PTGES 2, amyloid P components, transgelin, calponin 1, p20, 17 kD myosin light chain, H chain H Igg B12 and prolyl 4-hydroxylase beta subunit, or detecting decreased levels of one or more proteins selected from methylene tetrahydrofolate dehydrogenase 1, PRO2619, aldehyde dehydrogenase 1, fibrinogen alpha chain prepro protein, fructose bisphosphate aldolase B, argininosuccinate synthetase, Eef1a2, ATP5A1, alpha-2 actin, regucalcin, serum albumin, mitochondrial malate dehydrogenase and acetoacetyl-CoA thiolase. |
申请人 |
SCHMIEGEL, WOLFF;SIPOS, BENCE;SITEK, BARBARA;MEYER, HELMUT E.;STUEHLER, KAI |
发明人 |
SCHMIEGEL, WOLFF;SIPOS, BENCE;SITEK, BARBARA;MEYER, HELMUT E.;STUEHLER, KAI;KLOEPPEL, GUENTER |